• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COH
Click for more information
1.67% $293.02

COCHLEAR LIMITED - Announcements

Market Cap $18.63B  ! watchlist Created with Sketch. Add to my watchlist

Cochlear Limited is an Australia-based company, which provides implantable hearing... Cochlear Limited is an Australia-based company, which provides implantable hearing solutions and sound processors. The Company is engaged in development, manufacture and commercialization of implantable hearing solutions. Its segments include Cochlear implants, Services (sound processor upgrades and other) and Acoustics. The Company’s products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, and Recipient support tools. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check solution for cochlear implants. Its Cochlear implant portfolio include Cochlear Nucleus System. Its Acoustic solutions portfolio include Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
COHBecoming a substantial holder01/11/13
COHChange in substantial holding24/10/13
COHChange of Director's Interest Notice - Dr. Chris Roberts21/10/13
COHAppendix 3B18/10/13
COHAppendix 3B - Cochlear Employee Share Plan16/10/13
COHCOH 2013 AGM - Results of Meeting15/10/13
COH15/10/13 Cochlear AGM Presentation to Shareholders15/10/13
COH15/10/13 Chairmans AGM Address to ShareholdersPRICE SENSITIVE15/10/13
COHBecoming a substantial holder25/09/13
COHChange in substantial holding23/09/13
COHBecoming a substantial holder19/09/13
COHAnnual Report to Shareholders - Financials13/09/13
COHAnnual Report to Shareholders - Editorial13/09/13
COHNotice of Annual General Meeting13/09/13
COHVoting Form13/09/13
COHNotice of Annual General Meeting13/09/13
COHChange of Director's Interest Notice - Dr. Chris Roberts10/09/13
COHChange of Director's Interest Notice - Dr. Chris Roberts09/09/13
COHChange of Director's Interest Notice - Dr Chris Roberts22/08/13
COHChange of Director's Interest Notice - Dr Chris Roberts19/08/13
COHCOH Full Year Results Analyst Presentation 06.08.201306/08/13
COHCOH Full Year Results Media Release 06.08.1306/08/13
COHFull Year Statutory AccountsPRICE SENSITIVE06/08/13
COHChange in substantial holding24/06/13
COHCochlear Limited Investor Presentation17/06/13
COHCOH - Appendix 3Y14/06/13
COHChange of Director's Interest Notice - Dr Chris Roberts07/06/13
COHAppendix 3Y07/06/13
COHAppendix 3Y07/06/13
COHChange in substantial holding06/06/13
COHCeasing sub' holder Bank of New York Mellon Clarification04/06/13
COHCeasing to be a substantial holder03/06/13
COHCochlear Limited Market UpdatePRICE SENSITIVE03/06/13
COHAmended Becoming a substantial holder17/04/13
COHChange in substantial holding17/04/13
COHBecoming a substantial holder15/04/13
COHCochlear Half Year Report 201312/03/13
COHChange of Director's Interest Notice - Dr Chris Roberts08/03/13
COHChange of Director's Interest Notice - Dr Chris Roberts05/03/13
COHAppendix 3B04/03/13
COHChange of Director's Interest Notice - Dr Chris Roberts04/03/13
COHReplacement Appendix 3Y26/02/13
COHAppendix 3B25/02/13
COHChange of Director's Interest Notice - Dr Chris Roberts22/02/13
CBA +Ceasing to be a substantial holderfrom CBA22/02/13
COHAppendix 3B18/02/13
COHReplacement Change of Director's Interest Notice12/02/13
COHReplacement Change in Director's Interest Notice12/02/13
COHChange of Director's Interest Notice12/02/13
COHCeasing to be a substantial holder12/02/13
COHChange of Director's Interest Notice11/02/13
COHChange in substantial holding06/02/13
COHCOH Half Year Results Analyst Presentation 05.02.1305/02/13
COHCochlear Ltd Half Year Results Media Release 05.02.201305/02/13
COHHalf Yearly Report and AccountsPRICE SENSITIVE05/02/13
COHAppendix 3B21/12/12
COHChange in substantial holding12/12/12
COHChange in substantial holding20/11/12
COHAppendix 3B15/11/12
COHChange of Director's Interest Notice14/11/12
COHAppendix 3B12/11/12
COHChange of Director's Interest Notice09/11/12
COHReplacement Appendix 3B05/11/12
COHAppendix 3B05/11/12
COHAppendix 3B - Cochlear Employee Share Plan01/11/12
COHChange in substantial holding31/10/12
COHAppendix 3B29/10/12
COHChange of Director's Interest Notice29/10/12
COHAppendix 3B24/10/12
COHAppendix 3B22/10/12
COHCOH 2012 AGM - Results of Meeting16/10/12
COH16/10/12 Cochlear AGM Presentation to Shareholders16/10/12
COH16/10/12 Chairmans AGM Address to Shareholders16/10/12
COHAppendix 3B12/10/12
COHChange in substantial holding03/10/12
COHChairman's Letter13/09/12
COHVoting Form13/09/12
COHNotice of Annual General Meeting13/09/12
COHAnnual Report to shareholders - Financials13/09/12
COHAnnual Report to shareholders - Editorial13/09/12
COHChange of Director's Interest Notice10/09/12
ABY +S&P DJ Indices Announces September Quarterly Rebalance07/09/12
COHChange of Director's Interest Notice04/09/12
COHResponse to ASX Query28/08/12
COHChange of Director's Interest Notice24/08/12
COHAppendix 3B21/08/12
COHAppendix 3B - CELTIP Options20/08/12
COHChange of Director's Interest Notice13/08/12
COHAppendix 3B13/08/12
COHCOH Full Year Results Analyst Presentation 07.08.1207/08/12
COHCOH Update on Nucleus CI500 series implant recallPRICE SENSITIVE07/08/12
COHCOH Full Year Results ASX Release07/08/12
COHAppendix 4E and Full Year Statutory AccountsPRICE SENSITIVE07/08/12
COHBecoming a substantial holder05/06/12
COHPatent Infringement30/04/12
COHChange in substantial holding18/04/12
COHHalf Yearly Report and Accounts13/03/12
COHChange of Director's Interest Notice - Dr Chris Roberts05/03/12
COHAppendix 3B27/02/12
COHChange of Director's Interest Notice - Dr Chris Roberts24/02/12
COHBecoming a substantial holder
01/11/13
COHChange in substantial holding
24/10/13
COHChange of Director's Interest Notice - Dr. Chris Roberts
21/10/13
COHAppendix 3B
18/10/13
COHAppendix 3B - Cochlear Employee Share Plan
16/10/13
COHCOH 2013 AGM - Results of Meeting
15/10/13
COH15/10/13 Cochlear AGM Presentation to Shareholders
15/10/13
COH15/10/13 Chairmans AGM Address to Shareholders
15/10/13PRICE SENSITIVE
COHBecoming a substantial holder
25/09/13
COHChange in substantial holding
23/09/13
COHBecoming a substantial holder
19/09/13
COHAnnual Report to Shareholders - Financials
13/09/13
COHAnnual Report to Shareholders - Editorial
13/09/13
COHNotice of Annual General Meeting
13/09/13
COHVoting Form
13/09/13
COHNotice of Annual General Meeting
13/09/13
COHChange of Director's Interest Notice - Dr. Chris Roberts
10/09/13
COHChange of Director's Interest Notice - Dr. Chris Roberts
09/09/13
COHChange of Director's Interest Notice - Dr Chris Roberts
22/08/13
COHChange of Director's Interest Notice - Dr Chris Roberts
19/08/13
COHCOH Full Year Results Analyst Presentation 06.08.2013
06/08/13
COHCOH Full Year Results Media Release 06.08.13
06/08/13
COHFull Year Statutory Accounts
06/08/13PRICE SENSITIVE
COHChange in substantial holding
24/06/13
COHCochlear Limited Investor Presentation
17/06/13
COHCOH - Appendix 3Y
14/06/13
COHChange of Director's Interest Notice - Dr Chris Roberts
07/06/13
COHAppendix 3Y
07/06/13
COHAppendix 3Y
07/06/13
COHChange in substantial holding
06/06/13
COHCeasing sub' holder Bank of New York Mellon Clarification
04/06/13
COHCeasing to be a substantial holder
03/06/13
COHCochlear Limited Market Update
03/06/13PRICE SENSITIVE
COHAmended Becoming a substantial holder
17/04/13
COHChange in substantial holding
17/04/13
COHBecoming a substantial holder
15/04/13
COHCochlear Half Year Report 2013
12/03/13
COHChange of Director's Interest Notice - Dr Chris Roberts
08/03/13
COHChange of Director's Interest Notice - Dr Chris Roberts
05/03/13
COHAppendix 3B
04/03/13
COHChange of Director's Interest Notice - Dr Chris Roberts
04/03/13
COHReplacement Appendix 3Y
26/02/13
COHAppendix 3B
25/02/13
COHChange of Director's Interest Notice - Dr Chris Roberts
22/02/13
CBA +Ceasing to be a substantial holderfrom CBA
22/02/13
COHAppendix 3B
18/02/13
COHReplacement Change of Director's Interest Notice
12/02/13
COHReplacement Change in Director's Interest Notice
12/02/13
COHChange of Director's Interest Notice
12/02/13
COHCeasing to be a substantial holder
12/02/13
COHChange of Director's Interest Notice
11/02/13
COHChange in substantial holding
06/02/13
COHCOH Half Year Results Analyst Presentation 05.02.13
05/02/13
COHCochlear Ltd Half Year Results Media Release 05.02.2013
05/02/13
COHHalf Yearly Report and Accounts
05/02/13PRICE SENSITIVE
COHAppendix 3B
21/12/12
COHChange in substantial holding
12/12/12
COHChange in substantial holding
20/11/12
COHAppendix 3B
15/11/12
COHChange of Director's Interest Notice
14/11/12
COHAppendix 3B
12/11/12
COHChange of Director's Interest Notice
09/11/12
COHReplacement Appendix 3B
05/11/12
COHAppendix 3B
05/11/12
COHAppendix 3B - Cochlear Employee Share Plan
01/11/12
COHChange in substantial holding
31/10/12
COHAppendix 3B
29/10/12
COHChange of Director's Interest Notice
29/10/12
COHAppendix 3B
24/10/12
COHAppendix 3B
22/10/12
COHCOH 2012 AGM - Results of Meeting
16/10/12
COH16/10/12 Cochlear AGM Presentation to Shareholders
16/10/12
COH16/10/12 Chairmans AGM Address to Shareholders
16/10/12
COHAppendix 3B
12/10/12
COHChange in substantial holding
03/10/12
COHChairman's Letter
13/09/12
COHVoting Form
13/09/12
COHNotice of Annual General Meeting
13/09/12
COHAnnual Report to shareholders - Financials
13/09/12
COHAnnual Report to shareholders - Editorial
13/09/12
COHChange of Director's Interest Notice
10/09/12
ABY +S&P DJ Indices Announces September Quarterly Rebalance
07/09/12
COHChange of Director's Interest Notice
04/09/12
COHResponse to ASX Query
28/08/12
COHChange of Director's Interest Notice
24/08/12
COHAppendix 3B
21/08/12
COHAppendix 3B - CELTIP Options
20/08/12
COHChange of Director's Interest Notice
13/08/12
COHAppendix 3B
13/08/12
COHCOH Full Year Results Analyst Presentation 07.08.12
07/08/12
COHCOH Update on Nucleus CI500 series implant recall
07/08/12PRICE SENSITIVE
COHCOH Full Year Results ASX Release
07/08/12
COHAppendix 4E and Full Year Statutory Accounts
07/08/12PRICE SENSITIVE
COHBecoming a substantial holder
05/06/12
COHPatent Infringement
30/04/12
COHChange in substantial holding
18/04/12
COHHalf Yearly Report and Accounts
13/03/12
COHChange of Director's Interest Notice - Dr Chris Roberts
05/03/12
COHAppendix 3B
27/02/12
COHChange of Director's Interest Notice - Dr Chris Roberts
24/02/12
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
$293.02 		Change
-4.980(1.67%) 		Mkt cap ! $18.63B
Open High Low Value Volume
$300.33 $302.50 $290.30 $40.27M 136.9K

Buyers (Bids)

No. Vol. Price($)
1 83 $292.79
 

Sellers (Offers)

Price($) Vol. No.
$293.09 629 2
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
$292.65 		  Change
-4.980 ( 1.75 %)
Open High Low Volume
$301.49 $301.49 $290.32 25631
Last updated 15.59pm 21/11/2024 ?
COH (ASX) Chart

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.